Crossmark

Pterostilbene: a potential therapeutic agent for fibrotic diseases

Crossref DOI link: https://doi.org/10.1007/s10787-024-01440-z

Published Online: 2024-03-01

Published Print: 2024-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Wang, Wenhong

Li, Ke

Bai, Dandan

Wu, Jiabin

Xiao, Weihua https://orcid.org/0000-0003-1671-8140
License Information

Text and Data Mining valid from 2024-03-01

Version of Record valid from 2024-03-01
More Information

Article History

Received: 22 June 2023

Accepted: 19 January 2024

First Online: 1 March 2024

Declarations

:

: The authors declare no conflict of interest.